T2 Biosystems, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
SCHEDULE 13G/A: Major Investor Discloses 5.3% Stake in T2 Biosystems
Jacob Safier and JSAF Holdings, LLC have disclosed a 5.3% beneficial ownership stake in T2 Biosystems, Inc., holding 1,500,000 shares of common stock.
OTC.Pink
SCHEDULE 13G/A: Major Investor Discloses 5.3% Stake in T2 Biosystems
Jacob Safier and JSAF Holdings, LLC have disclosed a 5.3% beneficial ownership stake in T2 Biosystems, Inc., holding 1,500,000 shares of common stock.